Pharma Times

FEBRUARY 18, 2022

New combination treatment can significantly reduce the risk of death among prostate cancer patients

139

139

pharmaphorum

FEBRUARY 17, 2022

Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain associated with attention function. The results come from a single-arm, unblinded study of the app, but add to the clinical evidence that EndeavorRx can have a positive impact on children with ADHD which led it to become the prescription game to be approved by the FDA in 2020.

138

138

Outsourcing Pharma

FEBRUARY 17, 2022

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

115

115

NY Times

FEBRUARY 18, 2022

Beijing once said it had two mRNA shots within reach and ready for approval — one homemade and one produced by a foreign company. Today, neither are available.

Vaccines 98

Vaccines Immunity Immunization 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

FEBRUARY 15, 2022

Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA

Immunity 133

Immunity Immunization 133

pharmaphorum

FEBRUARY 18, 2022

The pandemic-induced transition to digital health is, according to the Nuffield Trust, contributing to an “inverse care law” that’s compounding existing health inequalities. But, as demonstrated by initiatives like the Telehealth Equity Coalition (TEC), the sector is taking a united stand against inequitable access. Technological solutions, from online clinics to app-based long-term condition management, have long been hailed as a solution to problems such as limited capacity and low patient aut

Compounding 123

Compounding 123

Drug Patent Watch

FEBRUARY 17, 2022

This chart shows the drugs with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Germany? appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Pharma Times

FEBRUARY 15, 2022

Oxford university spin out company develops tech to identify viruses in seconds

130

130

pharmaphorum

FEBRUARY 18, 2022

Sanofi and Regeneron have reported disappointing results in a trial of Dupixent in people with chronic spontaneous urticaria (CSU) who don’t respond to the only approved biologic treatment, Novartis/Roche’s Xolair. . CSU is a severe form of hives that affects around 1% of the global population, causing severe itching and swelling that can last for weeks at a time and resist even very high doses of antihistamines, the standard, first-line therapy for the condition.

Biosimilars 105

Biosimilars 105

NY Times

FEBRUARY 17, 2022

There has to be a better way out of the rubble of the past two years.

Immunity 93

Immunity Immunization Vaccines 93

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

FEBRUARY 18, 2022

This chart shows the pharmaceutical companies with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Cyprus? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Times

FEBRUARY 16, 2022

Saphnelo is the first therapy in over a decade for patients with moderate to severe systemic lupus erythematosus

113

113

pharmaphorum

FEBRUARY 15, 2022

One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study. The findings point to a “threat to environmental and global health,” say the scientists, who found that paracetamol, antibiotics epilepsy drug carbamazepine, metformin for diabetes and other compounds like caffeine and nicotine were found in samples from around the world – including in Antarctica.

Compounding 105

Compounding Pharmaceutical Manufacturing Diabetes 105

Outsourcing Pharma

FEBRUARY 15, 2022

The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.

92

92

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Drug Patent Watch

FEBRUARY 12, 2022

This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Pharma Times

FEBRUARY 17, 2022

Vaccine pioneers expand presence throughout Europe with a view to leveraging technology

Vaccines 113

Vaccines 113

pharmaphorum

FEBRUARY 18, 2022

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic hormone-sensitive tumours. The optimistic assessment of the revenue potential for androgen receptor inhibitor Nubeqa (darolutamide) follows the publication of the results of the phase 3 ARASENS trial in the New England Journal of Medicine.

Chemotherapy 98

Chemotherapy Labelling Diabetes 98

Drug Channels

FEBRUARY 15, 2022

Time to update Drug Channels' exclusive look at independent pharmacy owners’ business economics. Our analysis again reveals that despite what you may have heard, many independent pharmacies continue to hang on in a highly challenging retail environment. Prescription profits remained stable, while the average pharmacy owner’s salary jumped for the second year.

Independent Pharmacies 83

Independent Pharmacies Vaccines 83

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

FEBRUARY 15, 2022

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Switzerland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Switzerland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

Pharma Times

FEBRUARY 14, 2022

UK health secretary navigates the NHS roadmap as he plans to reform the UK’s healthcare ecosystem

106

106

pharmaphorum

FEBRUARY 16, 2022

An unexpected benefit of healthcare professional (HCP) engagement going digital in 2020 is that sales teams have more opportunities to spend quality time with doctors. Compared to traditional, face-to-face meetings, virtual meetings extended the amount of time HCPs were able to spend meeting with reps from an average of three minutes to 19 minutes. While the chance to engage in more meaningful conversations with doctors is a positive step for sales teams, marketers are under significant pressure

98

98

Drug Channels

FEBRUARY 18, 2022

Today’s guest post comes from Garry Marshall, Senior Director of Business Strategy at Wolters Kluwer, Health. Garry discusses healthcare business vertical integration and its effect on care quality for patients and on providers' work experiences. To learn more, download the Wolters Kluwer Expert Insight article Vertical Integration Strategies: Using Data to Align Partners and Reduce Variation in Care.

82

82

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

NY Times

FEBRUARY 13, 2022

The people who need treatments the most may be the least likely to get them. .

71

71

Pharma Times

FEBRUARY 18, 2022

Company focused on founding and building global leaders in life science sold to Novartis

105

105

pharmaphorum

FEBRUARY 14, 2022

A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic? In this feature, Ben Hargreaves looks at all of the factors involved and how the increased return can be maintained. The pharma industry has had a difficult time solving the issue of achieving greater productivity without significantly increasing the cost it takes to discover and commercialise new products.

Vaccines 98

Vaccines 98

Outsourcing Pharma

FEBRUARY 14, 2022

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

69

69

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

NY Times

FEBRUARY 18, 2022

El país había dicho que tenía dos vacunas con esta tecnología a su alcance y listas para ser aprobadas: una nacional y otra producida por una empresa extranjera. Hoy, ninguna de las dos está disponible.

Immunity 53

Immunity Immunization Vaccines 53

Pharma Times

FEBRUARY 16, 2022

Rare Disease Day has inspired a pioneering video to support patients living with rare conditions

102

102

pharmaphorum

FEBRUARY 13, 2022

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as early as possible in the drug discovery process. Quris’ BioAI safety prediction platform – which is based on human tissue samples on chips, nanosensors and machine learning – will be compared to traditional in vitro and in vivo laboratory techniques for spotting toxicity.

Compounding 98

Compounding Drug Development 98

Outsourcing Pharma

FEBRUARY 14, 2022

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

64

64

NY Times

FEBRUARY 18, 2022

Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del mundo.

Immunity 53

Immunity Immunization Vaccines 53